These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 316806)
21. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice. Takeichi N; Boone CW; Holden HT; Herberman RB Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543 [TBL] [Abstract][Full Text] [Related]
22. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation. Jones DB; Moore M Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943 [TBL] [Abstract][Full Text] [Related]
24. Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors. Gordon J; Holden HT; Segal S; Feldman M Int J Cancer; 1982 Mar; 29(3):351-7. PubMed ID: 6978293 [TBL] [Abstract][Full Text] [Related]
25. Hormonal-like modulation of growth of moloney virus-induced tumors by interferon and platelet-derived growth factor. Inglot AD; Inglot O Arch Immunol Ther Exp (Warsz); 1983; 31(2):243-8. PubMed ID: 6197039 [TBL] [Abstract][Full Text] [Related]
26. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138 [TBL] [Abstract][Full Text] [Related]
28. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945 [TBL] [Abstract][Full Text] [Related]
29. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
30. Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen. Powell TJ; Spann R; Vakil M; Kearney JF; Lamon EW J Immunol; 1988 May; 140(9):3266-72. PubMed ID: 3258895 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses. Cicurel L; Lee JC; Enjuanes L; Ihle JN Transplant Proc; 1980 Sep; 12(3):394-7. PubMed ID: 7222218 [No Abstract] [Full Text] [Related]
33. Platelet-derived growth factor (PDGF) enhances the growth of Moloney sarcoma virus-induced tumors in mice. Inglot AD; Inglot O Arch Immunol Ther Exp (Warsz); 1981; 29(4):431-7. PubMed ID: 7332446 [TBL] [Abstract][Full Text] [Related]
34. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. Enjuanes L; Lee JC; Ihle JN J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033 [No Abstract] [Full Text] [Related]
35. Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity. Epstein LB; Knight RA Br J Cancer; 1975 May; 31(5):513-23. PubMed ID: 50853 [TBL] [Abstract][Full Text] [Related]
36. Isotype distribution and specificity of the antibody response to primary Moloney murine sarcoma virus infection in BALB/c mice. Powell TJ; Gaupp B; Epps JM; Srinivas RV; Lamon EW Viral Immunol; 1989; 2(2):89-101. PubMed ID: 2673279 [TBL] [Abstract][Full Text] [Related]